S-268019
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for S-268019, covering 2025-11-28 to 2025-11-28. Get the full timeline:
Most recent: Clinical Trial Update: A Study of S-268019 for the Prevention of COVID-19 [Phase 3]